临床结果和基因组分析之间的相关性与骨髓瘤进展的高风险因素
Weifeng Liu1,2,3, Huanqing Cheng4, Zhen Huang1,2,3
1Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University, Beijing, China.
Molecular oncology
|September 20, 2023
概括
这项研究揭示了中国和西方患者骨髓瘤 (OS) 的关键基因组差异. 特定的DNA损伤修复变化和拷贝数变化与较差的生存率有关,有助于OS的精准医学.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 骨髓瘤 (OS) 是一种具有不太清楚分子驱动因素的侵袭性骨癌.
- 对于中国的OS患者群体,基因组数据有限.
研究的目的:
- 描述中国患者骨髓瘤的基因组景观.
- 为了比较中国和西方OS队伍的基因组资料.
- 确定与OS进展和生存相关的分子因素.
主要方法:
- 73个中国骨髓瘤病例的基因组测序.
- 与西方OS患者基因组数据进行比较分析.
- 研究DNA损伤修复突变,拷贝数变异,体积变异和内异质性的研究.
主要成果:
- 在中国的OS中,TP53,NCOR1,LRP1B,ATRX,RB1和TFE3经常发生突变.
- 在中国和西方队伍之间观察到突变格局和瘤突变负担的显著差异.
- 修复DNA损伤的基因突变,拷贝数的变异,积体和异质性与疾病进展相关.
- 30.1%的患者在PI3K,MAPK,DDR和RTK路径中出现了可操作的变化.
- 一种具有DNA损伤修复变化和拷贝数变化的亚型预测了较差的远程无转移和无事件生存率.
结论:
- 这项研究提供了中国骨髓瘤的综合基因组概况.
- 确定了新的预后因素,包括DNA损伤修复变化和副本数量变化.
- 这些发现支持开发精准医学策略来治疗骨髓瘤,特别是在中国人群中.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381


